Wealth Enhancement Advisory Services, LLC Aldeyra Therapeutics, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 27,286 shares of ALDX stock, worth $150,073. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,286
Previous 10,910
150.1%
Holding current value
$150,073
Previous $62,000
67.74%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ALDX
# of Institutions
132Shares Held
34.9MCall Options Held
244KPut Options Held
51.6K-
Knoll Capital Management, LLC Miami, FL5.48MShares$30.1 Million14.27% of portfolio
-
Perceptive Advisors LLC New York, NY4.05MShares$22.3 Million0.68% of portfolio
-
Black Rock Inc. New York, NY3.62MShares$19.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.5MShares$19.3 Million0.0% of portfolio
-
Ardsley Advisory Partners LP Stamford, CT2.05MShares$11.3 Million1.29% of portfolio
About Aldeyra Therapeutics, Inc.
- Ticker ALDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,323,100
- Market Cap $321M
- Description
- Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...